13601 BMS-986165, an oral selective TYK2 inhibitor, in the treatment of moderate to severe psoriasis as assessed by the static Physicians Global Assessment/body surface area composite tool, a clinically useful alternative to the Psoriasis Area and Severity Index score

Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2020
This article has no abstract
Epistemonikos ID: 35e9318df1b299cb926d0cc534d99985261fcade
First added on: Feb 12, 2025